Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
15 Mar 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/immviras-oncolytic-product-mvr-t3011-it-intratumoral-injection-receives-fda-fast-track-designation-for-hnscc-treatment-302090155.html
09 Nov 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-approves-first-vaccine-to-prevent-disease-caused-by-chikungunya-virus-301984081.html
22 Aug 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/immvira-appoints-howard-l-kaufman-md-as-consulting-medical-advisor-301907504.html
06 Jun 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/immvira-presented-latest-encouraging-clinical-results-of-two-proprietary-products-at-asco-2023-301843794.html
29 Mar 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/immviras-oncolytic-product-mvr-c5252-targeting-malignant-glioma-obtained-nmpas-approval-for-clinical-trial-in-china-301784765.html
08 Feb 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/immvira-clinical-snapshot-intratumoral-injected-ov-mvr-t3011-it-monotherapy-achieved-median-pfs-of-12-9-months-on-treatment-of-melanoma-301742055.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?